Ciclofosfamida versus ifosfamida para niños y adultos jóvenes con sarcoma de tejidos blandos y óseo
Información
- DOI:
- https://doi.org/10.1002/14651858.CD006300.pub4Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 30 septiembre 2015see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Cáncer infantil
- Copyright:
-
- Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Renée L Mulder assessed studies against the inclusion criteria. She searched for unpublished and ongoing studies. She contributed to the interpretation of the results. She wrote and revised the review.
Marios Paulides designed the review and wrote the protocol. He assessed studies against the inclusion criteria. He contributed to the interpretation of the results. He critically reviewed the review.
Thorsten Langer critically reviewed the protocol. He contributed to the interpretation of the results. He critically reviewed the review.
Leontien CM Kremer designed the review and critically reviewed the protocol. She contributed to the interpretation of the results. She critically reviewed the review.
Elvira C van Dalen designed the review and wrote the protocol. She developed the search strategy. She assessed studies against the inclusion criteria. She searched for unpublished and ongoing studies. She interpreted the results. She wrote and revised the review.
All authors approved the final version.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
Foundation of Pediatric Cancer Research (SKK) Amsterdam, Netherlands.
-
Stichting Kinderen Kankervrij (KIKA), Netherlands.
Declarations of interest
None known.
Acknowledgements
Leontien Kremer and Elvira van Dalen, the Co‐ordinating Editors of the Childhood Cancer Group, are co‐authors of this review and therefore they could not act as the Co‐ordinating Editors for this review. Wim J Tissing (Department of Pediatric Oncology/Hematology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands) was willing to take on this task, for which we thank him. Also, we thank Edith Leclercq, the Trials Search Co‐ordinator of the Childhood Cancer Group, for running the search strategy in the different databases and providing us with the titles and abstracts of the searches, and Wolfgang Stöhr for his help in preparing the protocol for this review. The editorial base of the Cochrane Childhood Cancer Group is funded by Kinderen Kankervrij (KIKA).
Version history
| Published | Title | Stage | Authors | Version |
| 2015 Sep 30 | Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients | Review | Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen | |
| 2012 Dec 12 | Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients | Review | Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen | |
| 2010 Feb 17 | Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients | Review | Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen | |
| 2006 Oct 18 | Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients | Protocol | Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen | |
Keywords
MeSH
Medical Subject Headings (MeSH) Keywords
Medical Subject Headings Check Words
Adult; Child; Humans; Young Adult;
